ID1 and B-cell non-Hodgkin lymphoma: Fusion of a chimeric antibody containing the 38C13 murine B cell lymphoma Id to CD40L improved immunogenicity compared to administration of the antibody alone, to levels similar to those of an Id/GM-CSF fusion protein (Huang et al., 2004).